The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype

European Respiratory Journal

Volumn 25, Issue 3, 2005, Pages 468-473

  Dugueperoux I ^a   De Braekeleer, Marc ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

2789+5G >A; 3849+10kbC >T; Cystic fibrosis; Genotype phenotype; Mild allele

Indexed keywords

ADENINE; CHLORIDE; CYTOSINE; GUANINE; MESSENGER RNA; THYMINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGE DISTRIBUTION; ALLELE; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRANCE; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; LIFE EXPECTANCY; LUNG FUNCTION TEST; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PANCREAS INSUFFICIENCY; PREVALENCE; PRIORITY JOURNAL; REGISTER; RNA SPLICING; SEX DIFFERENCE; STATISTICAL ANALYSIS; SWEAT TEST;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; ALLELES; BODY SIZE; COMORBIDITY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; FRANCE; GENOTYPE; HUMANS; LIFE EXPECTANCY; MALE; PHENOTYPE; REGISTRIES; SEX DISTRIBUTION;

EID: 14744303133     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.10100004     Document Type: Article

References (33)

1. Rommens JM, Iannuzzi MC, Kerem BS, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
2. Riordan JR, Rommens JM, Kerem BS, et al. Identification of the cystic fibrosis gene: cloning and characterization of complentary DNA. Science 1989; 245: 1066-1073.
3. Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
4. International Cystic Fibrosis Genetics Research Community. Cystic fibrosis mutation database. http://genet.sickkids.on.ca/cftr/ Date last updated: continuous.
5. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993; 329: 1308-1313.
6. Gan KH, Heijerman HGM, Bakker W. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1994; 330: 865-866.
7. Kraemer R, Birrer P, Liechti-Gallati S. Genotype-phenotype association in infants with cystic fibrosis at the time of diagnosis. Pediatr Res 1998; 44: 920-926.
8. Hubert D, Bienvenu T, Desmazes-Dufeu N, et al. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. Eur Respir J 1996; 9: 2207-2214.
9. De Braekeleer M, Bellis G. Observatoire national de la mucoviscidose (ONM): structure de l'observatoire et résultats de l'enquête 1999 [Observatoire national de la mucoviscidose (ONM): structure of the registry and results from the 1999 enquiry]. Référence Mucoviscidose 2001; 6: 42-48.
10. De Braekeleer M, Allard C, Leblanc J-P, Simard F, Aubin G. Genotype-phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation. Hum Genet 1997; 101: 208-211.
11. Duguépéroux I, Bellis G, Férec C, Gillet D, Scotet V, De Braekeleer M. Relationship between genotype and phenotype for the CFTR gene W846X mutation. J Med Genet 2002; 39: E32.
12. Duguépéroux I, Bellis G, Lesure JF, Renouil M, Flodrops H, De Braekeleer M. Cystic fibrosis at the Reunion Island (France): spectrum of mutations and genotype-phenotype for the Y122X mutation. J Cyst Fibros 2004; 3: 185-188.
13. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1995; pp. 3799-3876.
14. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
15. Sempé M. Auxologie - méthode et séquences. Méditions, Lyon, 1997.
16. Highsmith WE, Burch LH, Zhou Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994; 331: 974-980.
17. Estivill X, Bancells C, Ramos C, Biomed CF mutation Analysis Consortium. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. Hum Mutat 1997; 10: 135-154.
18. Abeliovich D, Lavon IP, Lerer I, et al. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet 1992; 51: 951-956.
19. Czerska K, Sobczynska-Tomaszewska A, Bal J. Frequency of occurring of the 3849+10kb C>T mutation in Polish CF patients is significantly higher than in most of other populations. J Cyst Fibros 2004; 3: Suppl. 2, S8.
20. Witt M, Pogorzelski A, Bal J, Rutkiewicz E, Majka L, Sobczynska A. Frequency of mutations and genotypes of the CFTR gene in cystic fibrosis adults in Poland. Pneumonol Alergol Pol 1999; 67: 137-141.
21. Liang MH, Wertz KK, Bowman CM, Hsu E, Shapiro B, Wong LJC. 3849+10kb C->T splicing mutation in Hispanic CF patients. Mol Genet Metab 1998; 64: 213-216.
22. Mercier B, Raguénès O, Estivill X, et al. Complete detection of mutations in cystic fibrosis patients of Native American origin. Hum Genet 1994; 94: 629-632.
23. Morral N, Llevadot R, Casals T, et al. Independent origins of cystic fibrosis mutations R334W, R347P, R1162X, and 3849+10kbC->T provide evidence of mutation recurrence in the CFTR gene. Am J Hum Genet 1994; 55: 890-898.
24. Augarten A, Kerem BS, Yahav Y, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+0kb C->T mutation. Lancet 1993; 342: 25-26.
25. Gilbert F, Li Z, Arzimanoglou I, et al. Clinical spectrum in homoygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849+10kb C>T: Significance for geneticists. Am J Med Genet 1995; 58: 356-359.
26. Stern RC, Doershuk CF, Drumm ML. 3839+10kb C->T mutation and disease severity in cystic fibrosis. Lancet 1995; 346: 274-276.
27. Feldmann D, Couderc R, Audrezet MP, et al. CFTR genotypes in patients with normal or borderline sweat chloride levels. Hum Mutat 2003; 22: 340-347.
28. Highsmith WEJ, Burch LH, Zhou Z, et al. Identification of a splice site mutation (2789+5G->A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis. Hum Mutat 1997; 9: 332-338.
29. Claustres M, Guittard C, Bozon D, et al. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 2000; 16: 143-156.
30. Muco 2000. Rapport sur la situation de la mucoviscidose en France en 2000 [Report on the cystic fibrosis situation in France in 2000]. Paris, Vaincre la Mucoviscidose et Institut National d'Etudes Démographiques, 2002.
31. Gan KH, Geus WP, Bakker W, Lamers CBHW, Heijerman HGM. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years. Thorax 1995; 50: 1301-1304.
32. Widerman E, Millner L, Sexauer W, Fiel S. Health status and sociodemographic characterisitics of adults receiving a cystic fibrosis diagnosis after age 18 years. Chest 2000; 118: 427-433.
33. Gilljam M, Ellis L, Corey M, Zielanski J, Durie P, Tullis DE. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004; 126: 1215-1224.